Last reviewed · How we verify
NCT03237143
Low-intensity Extracorporeal Shock Wave for Erectile Disfunction
trial in Erectile Dysfunction in 710 participants. Terminated before completion.
30 January 2016
Quick facts
| Lead sponsor | Boston Medical Group |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 710 |
| Start date | 1 June 2015 |
| Primary completion | 30 January 2016 |
| Estimated completion | 30 June 2016 |
Conditions studied
- Erectile Dysfunction — all drugs for Erectile Dysfunction →
Sponsor
Boston Medical Group — full company profile →
Who can join
18 and older, male only, with Erectile Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Erectile dysfunction occurs in a high percentage of patients today, showing not only an association with various pathologies but also frequent refractoriness to conventional pharmacological treatment options such as monotherapy. The objective of this study is to evaluate the response to low-intensity extracorporeal shock wave therapy in a group of patients with organic vascular erectile dysfunction with a history of more than three months. Materials and Methods: Observational retrospective study. The researchers reviewed clinical records of patients with a clinical diagnosis of organic vascular erectile dysfunction (ED) of more than 3 months duration, who received 5 outpatient shock wave therapy sessions, in the male sexual health clinics of the Boston Medical Group from Spain and Mexico. The patients were evaluated with the erection hardness score (EHS) before the first session, at the end of the last session and one month after the last session.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact on the Quality of Erections after Completing a Low-Intensity Extracorporeal Shock Wave Treatment Cycle on a Group of 710 Patients.
Ayala HAC, Cuartas JPS, Cleves DC. · · 2017 · cited 7× · PMID 29430250 · DOI 10.1155/2017/1843687
Verify or expand the search:
- PubMed search for NCT03237143
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Erectile Dysfunction
Currently open trials in the same condition.
- NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
- NCT07366970 — Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? · NA · recruiting
- NCT06960746 — Changing Lifestyle in OSA Males Who Suffer Metabolic Syndrome and Impotence: Is There a Response? · NA · recruiting
- NCT06872866 — The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under · Phase 1 · recruiting
- NCT06805513 — Actual Use Trial of Tadalafil 5 mg · Phase 3 · recruiting
Other Boston Medical Group trials
Trials by the same sponsor.
- NCT03596047 — Radial Shockwave Therapy for Erectile Dysfunction · NA · completed
- NCT03308409 — Comparative Effectiveness and Safety of Three Protocols Usin Li-ESWT for Erectile Dysfunction · NA · completed
- NCT03204890 — TPTNS for Treating Patients With Premature Ejaculation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03237143 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Medical Group
- Last refreshed: 5 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03237143.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing